Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115902030> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2115902030 endingPage "76" @default.
- W2115902030 startingPage "71" @default.
- W2115902030 abstract "The overall cure rate of adults with newly-diagnosed acute myelogenous leukemia (AML) treated with continuous infusion high-dose cytarabine (CIHDAC) is comparable to that with standard-dose ara-C plus anthracycline or amsacrine (AMSA). We tested whether the addition of AMSA to CIHDAC improves the outcome of adults with untreated AML. 75 patients with untreated AML were treated with AMSA (75 mg/m2/day x 4) plus CIHDAC (1.5 g/m2/day x 4) for induction and, if in complete remission (CR), early and late intensification. Results were compared to those in 129 patients treated on a previous study with CIHDAC alone. The principal comparison in both groups was between those 117 patients (AMSA/CIHDAC n = 52, CIHDAC n = 65) who met the initial eligibility criteria for the AMSA/CIHDAC study (risk of early mortality ≤. 1) and who were treated at a time when relatively few eligible patients were excluded (19% in the AMSA/CIHDAC group, 34% in the CIHDAC group). There was no difference between regimens in CR rate, remssion duration, or survival in this cohort. When attention was turned to all 204 patients, outcome was superior with AMSA/CIHDAC very largely as a result of outcome in patients with APL. Aside from these patients, addition of amsacrine to CIHDAC did not appear to be productive." @default.
- W2115902030 created "2016-06-24" @default.
- W2115902030 creator A5007601705 @default.
- W2115902030 creator A5027575595 @default.
- W2115902030 creator A5030500582 @default.
- W2115902030 creator A5038302480 @default.
- W2115902030 creator A5057920623 @default.
- W2115902030 creator A5090435894 @default.
- W2115902030 date "1996-01-01" @default.
- W2115902030 modified "2023-09-27" @default.
- W2115902030 title "Amsacrine and Continuous-Infusion High-Dose Cytosine Arabinoside as Induction Therapy for Patients with Newly-Diagnosed Acute Myelogenous Leukemia" @default.
- W2115902030 cites W1481564836 @default.
- W2115902030 cites W171565781 @default.
- W2115902030 cites W1937894144 @default.
- W2115902030 cites W1990261520 @default.
- W2115902030 cites W1998370534 @default.
- W2115902030 cites W2008429524 @default.
- W2115902030 cites W2047692316 @default.
- W2115902030 cites W2053450804 @default.
- W2115902030 cites W2064608254 @default.
- W2115902030 cites W2076477731 @default.
- W2115902030 cites W2180813806 @default.
- W2115902030 cites W2211072972 @default.
- W2115902030 cites W2263355311 @default.
- W2115902030 cites W2403598312 @default.
- W2115902030 cites W2406249232 @default.
- W2115902030 doi "https://doi.org/10.3109/10428199609051730" @default.
- W2115902030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8724530" @default.
- W2115902030 hasPublicationYear "1996" @default.
- W2115902030 type Work @default.
- W2115902030 sameAs 2115902030 @default.
- W2115902030 citedByCount "4" @default.
- W2115902030 countsByYear W21159020302017 @default.
- W2115902030 crossrefType "journal-article" @default.
- W2115902030 hasAuthorship W2115902030A5007601705 @default.
- W2115902030 hasAuthorship W2115902030A5027575595 @default.
- W2115902030 hasAuthorship W2115902030A5030500582 @default.
- W2115902030 hasAuthorship W2115902030A5038302480 @default.
- W2115902030 hasAuthorship W2115902030A5057920623 @default.
- W2115902030 hasAuthorship W2115902030A5090435894 @default.
- W2115902030 hasConcept C121608353 @default.
- W2115902030 hasConcept C126322002 @default.
- W2115902030 hasConcept C2776023528 @default.
- W2115902030 hasConcept C2776694085 @default.
- W2115902030 hasConcept C2776802502 @default.
- W2115902030 hasConcept C2778041864 @default.
- W2115902030 hasConcept C2778119113 @default.
- W2115902030 hasConcept C2778461978 @default.
- W2115902030 hasConcept C2780500152 @default.
- W2115902030 hasConcept C530470458 @default.
- W2115902030 hasConcept C54355233 @default.
- W2115902030 hasConcept C552990157 @default.
- W2115902030 hasConcept C71924100 @default.
- W2115902030 hasConcept C86803240 @default.
- W2115902030 hasConcept C90924648 @default.
- W2115902030 hasConceptScore W2115902030C121608353 @default.
- W2115902030 hasConceptScore W2115902030C126322002 @default.
- W2115902030 hasConceptScore W2115902030C2776023528 @default.
- W2115902030 hasConceptScore W2115902030C2776694085 @default.
- W2115902030 hasConceptScore W2115902030C2776802502 @default.
- W2115902030 hasConceptScore W2115902030C2778041864 @default.
- W2115902030 hasConceptScore W2115902030C2778119113 @default.
- W2115902030 hasConceptScore W2115902030C2778461978 @default.
- W2115902030 hasConceptScore W2115902030C2780500152 @default.
- W2115902030 hasConceptScore W2115902030C530470458 @default.
- W2115902030 hasConceptScore W2115902030C54355233 @default.
- W2115902030 hasConceptScore W2115902030C552990157 @default.
- W2115902030 hasConceptScore W2115902030C71924100 @default.
- W2115902030 hasConceptScore W2115902030C86803240 @default.
- W2115902030 hasConceptScore W2115902030C90924648 @default.
- W2115902030 hasIssue "1-2" @default.
- W2115902030 hasLocation W21159020301 @default.
- W2115902030 hasLocation W21159020302 @default.
- W2115902030 hasOpenAccess W2115902030 @default.
- W2115902030 hasPrimaryLocation W21159020301 @default.
- W2115902030 hasRelatedWork W151993192 @default.
- W2115902030 hasRelatedWork W2002493774 @default.
- W2115902030 hasRelatedWork W2013258656 @default.
- W2115902030 hasRelatedWork W2115902030 @default.
- W2115902030 hasRelatedWork W2144803172 @default.
- W2115902030 hasRelatedWork W2185043428 @default.
- W2115902030 hasRelatedWork W2410632462 @default.
- W2115902030 hasRelatedWork W2413272328 @default.
- W2115902030 hasRelatedWork W2417568829 @default.
- W2115902030 hasRelatedWork W2495138153 @default.
- W2115902030 hasVolume "22" @default.
- W2115902030 isParatext "false" @default.
- W2115902030 isRetracted "false" @default.
- W2115902030 magId "2115902030" @default.
- W2115902030 workType "article" @default.